The Philadelphia Phillies and Asplundh raised $800,004 for ALS research and care during ALS Awareness Night on June 9, 2025.

Usnoflast is an orally available small molecule that's designed to reduce inflammation, a key contributor to nerve cell ...

Corcept Therapeutics Incorporated (NASDAQ:CORT) said on Thursday that it presented results from its Phase 2 DAZALS study of ...

The Phillie Phanatic has been known to bust some pretty impressive moves over the years, from choreographed skits on the ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...

Corcept Therapeutics has tried to cast its recent phase 2 amyotrophic lateral sclerosis (ALS) failure in a more flattering ...

UC Irvine researchers conducted a study to better understand the molecular basis of amyotrophic lateral sclerosis (ALS), a ...

He was also a Vietnam combat veteran, and served as captain and battery commander of the 23rd Artillery Group in areas near ...

The Australian Government is providing a further $4.5 million and listing another treatment to ensure the continuing battle against motor neurone ...

Prescribed use of anti-anxiety drugs, hypnotics and sedatives, or antidepressants was tied to a higher future risk of ...

Corcept Therapeutics' dazucorilant failed the primary ALS trial goal but showed improved survival outcomes and a safe profile ...

Amylyx Pharmaceuticals ( NASDAQ: AMLX) said on Tuesday that the U.S. FDA has granted fast track status to its antisense RNA, ...